berbamine

N/A

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug Nameberbamine
Drug Alias Name小檗胺
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium/Calmodulin dependent protein kinase II inhibitors
TargetsCalcium/Calmodulin dependent protein kinase II
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIsoQ Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIsoQ Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A